LWM Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
901
+73
+9% +$74.6K 1.93% 12
2026
Q1
$762K Sell
828
-71
-8% -$72K 0.81% 24
2025
Q4
$966K Sell
899
-690
-43% -$660K 0.57% 32
2025
Q3
$1.22M Sell
1,589
-109
-6% -$81.1K 0.71% 26
2025
Q2
$1.32M Hold
1,698
0.91% 24
2025
Q1
$1.4M Sell
1,698
-146
-8% -$121K 0.97% 22
2024
Q4
$1.42M Buy
1,844
+43
+2% +$35.6K 0.99% 22
2024
Q3
$1.6M Sell
1,801
-17
-0.9% -$15.3K 1.18% 18
2024
Q2
$1.65M Buy
1,818
+28
+2% +$22.4K 1.38% 18
2024
Q1
$1.39M Sell
1,790
-9
-0.5% -$6.41K 1.12% 22
2023
Q4
$1.05M Buy
1,799
+32
+2% +$18.7K 0.92% 22
2023
Q3
$949K Sell
1,767
-8
-0.5% -$4.12K 1.02% 20
2023
Q2
$833K Hold
1,775
0.88% 22
2023
Q1
$610K Buy
1,775
+209
+13% +$70.5K 0.65% 31
2022
Q4
$573K Sell
1,566
-239
-13% -$84.7K 0.63% 34
2022
Q3
$584K Buy
1,805
+43
+2% +$13.6K 0.66% 41
2022
Q2
$571K Buy
1,762
+1,035
+142% +$311K 0.68% 41
2022
Q1
$208K Buy
+727
New +$187K 0.26% 109

Other funds holding LLY

LWM Advisory Services's LLY Position: Q2 2026 in Review

LWM Advisory Services increased its Eli Lilly (LLY) stake by 8.8% in Q2 2026, buying an estimated $74.6K and bringing the position to 901 shares worth $1.08M. The position accounts for 1.93% of the portfolio, ranked #12.

LWM Advisory Services first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.65M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LWM Advisory Services held 901 shares of Eli Lilly worth $1.08M as of Q2 2026.
  • LWM Advisory Services bought 73 Eli Lilly shares in Q2 2026, an estimated $74.6K.
  • Eli Lilly made up 1.93% of LWM Advisory Services's portfolio in Q2 2026, its #12 holding.
  • LWM Advisory Services first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • LWM Advisory Services's Eli Lilly position peaked at $1.65M in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LWM Advisory Services's 13F filing for Q2 2026, filed 3 Aug 2026.